Sheffield Medical Technologies Inc. regulatory update

SHEF said U.S. Patent No. 5,236,835 will issue Aug. 17 covering the electro-insertion technology used to produce its red blood cell (RBC)-CD4 therapy for the treatment of HIV infection and AIDS. The c...